A Single-blind, Randomised, Vehicle-controlled Dose-finding Study of Recombinant Human Granulocyte Colony-stimulating Factor (Lenograstim) in Patients Undergoing Chemotherapy for Solid Cancers and Lymphoma

Author: Seymour A.-M.   de Campos E.   Thatcher N.   De Greve J.   Cunningham D.   Howell A.   Tueni E.   Bron D.G.   Steward W.P.   Berdel W.E.   Knuth A.   Lorenz J.   Timothy A.R.   Yver A.   Richards M.A.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.31, Iss.13, 1995-12, pp. : 2157-2163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content